Flexion Therapeutics Sees Prelim. Q4 Sales $23.7M vs $24.15M Est., Prelim. FY19 Sales $73M vs $73.43M Est.; Sees FY20 Product Revenues $120M-$135M

Benzinga · 01/09/2020 21:03